Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant enterococcus faecium carrying both vanA and vanB genes

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 2, 2014, Pages 500-505

  Marcade G ^a,b,c,d   Micol, J B ^b,e   Jacquier, H ^a,c   Raskine, L ^a   Donay, J L ^b   Nicolas Viaud, S ^b   Rouveau, M ^b   Ribaud, P ^b,e   Dombret, H ^b,e   Leclercq, R ^f   Cambau, E ^a,c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL LOUIS MOURIER   (France)

^e UNIVERSITÉ PARIS DIDEROT   (France)

^f CHU CÔTE DE NACRE   (France)

Author keywords

Contact precautions; Febrile neutropenia; GeneXpert VRE assay; Nosocomial infections; Vancomycin resistant enterococci

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; KANAMYCIN; LINEZOLID; NITROFURANTOIN; PRISTINAMYCIN; RIFAMPICIN; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; GENETIC TRAIT; GLYCOPEPTIDE RESISTANT ENTEROCOCCUS FAECIUM; HEMATOLOGY; HOSPITALIZATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; VANA GENE; VANB GENE;

CONTACT PRECAUTIONS; FEBRILE NEUTROPENIA; GENEXPERT VRE® ASSAY; NOSOCOMIAL INFECTIONS; VANCOMYCIN-RESISTANT ENTEROCOCCI;

BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; DISEASE OUTBREAKS; ENTEROCOCCUS FAECIUM; FRANCE; GLYCOPEPTIDES; HEMATOLOGIC DISEASES; HOSPITAL UNITS; HUMANS; VANCOMYCIN RESISTANCE;

EID: 84892451332     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt376     Document Type: Article

References (22)

1. Werner G, Coque TM, Hammerum AM et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 2008;13: pii=19046.
2. Salgado CD, Farr BM. Outcomes associated with vancomycin-resistant enterococci:ameta-analysis. Infect ControlHospEpidemiol 2003; 24: 690-8.
3. Chang S, Sievert DM, Hageman JC et al. Infection with vancomycinresistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348: 1342-7.
4. Fournier S, Brossier F, Fortineau N et al. Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience. Euro Surveill 2012; 17: pii=20229.
5. Woodford N. Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci. Microb Drug Resist 2001;7: 229-36.
6. Fournier S, Brun-Buisson C, Jarlier V. Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE). Antimicrob Resist Infect Control 2012; 1: 9.
7. Freifeld AG, Bow EJ, Sepkowitz KA et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52: e56-93.
8. Miranda AG, Singh KV, Murray BE. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J Clin Microbiol 1991; 29: 2752-7.
9. Werner G, Fleige C, Geringer U et al. IS element IS16 as a molecular screening tool to identify hospital-associated strains of Enterococcus faecium. BMC Infect Dis 2011; 11: 80.
10. Jacob AE, Hobbs SJ. Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes. J Bacteriol 1974; 117: 360-72.
11. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995; 33: 1434.
12. Kieser T. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 1984; 12: 19-36.
13. Nourse C, Murphy H, Byrne C et al. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. Eur J Pediatr 1998; 157: 20-7.
14. Timmers GJ, van der Zwet WC, Simoons-Smit IM et al. Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic. Br J Haematol 2002; 116: 826-33.
15. Bourdon N, Bérenger R, Lepoultier R et al. Rapid detection of vancomycin-resistant enterococci from rectal swabs by the Cepheid Xpert vanA/vanB assay. Diagn Microbiol Infect Dis 2010; 67: 291-3.
16. Babady NE, Gilhuley K, Cianciminio-Bordelon D et al. Performance characteristics of the Cepheid Xpert vanA assay for rapid identification of patients at high risk for carriage of vancomycin-resistant enterococci. J Clin Microbiol 2012; 50: 3659-63.
17. Stinear TP, Olden DC, Johnson PD et al. Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet 2001; 357: 855-6.
18. Woodford N, Chadwick PR, Morrison D et al. Strains of glycopeptideresistant Enterococcus faecium can alter their van genotypes during an outbreak. J Clin Microbiol 1997; 35: 2966-8.
19. Dendle C, Ballard SA, Grabsch EA et al. Outbreak of vancomycinresistant Enterococcus faecium containing both vanA and vanB gene clusters. J Hosp Infect 2009; 71: 379-81.
20. Suppola JP, Kolho E, Salmenlinna S et al. vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality. J Clin Microbiol 1999;37: 3934-9.
21. Al-Ahdal MN, Abozaid SM, Al-Shammary HF et al. Characterization of Enterococcus faecium isolates and first report of vanB phenotype-vanA genotype incongruence in the Middle East. Eur J Clin Microbiol Infect Dis 2012; 31: 3223-9.
22. Fournier S, Lepainteur M, Kassis-Chikhani N et al. Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution. J Travel Med 2012; 19: 320-3.